TrialBreast cancer research and treatment2021

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.

Rebecca Dent et al.PubMed ↗Publisher ↗

No numbers read from the abstract.